Search results
Study Allegedly Connects Excess Deaths to Vaccines During COVID-19 Pandemic. Here Are the Facts
Snopes via Yahoo News· 10 hours agoMortality Dataset. According to the BMJ study, there were more than 3 million excess deaths between...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 12 hours agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
Moderna’s Covid-19 vaccine meets primary efficacy endpoint in Phase III trial
Clinical Trials Arena via Yahoo Finance· 14 hours agoThe observer-blind, randomised, active-controlled study involved approximately 11,400 participants...
US Government to Fund up to $500 Million for Studies on Oral, Nasal COVID Vaccines
US News & World Report· 1 day agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines ...
Health experts offer safety assurances as HPV vaccine rates drop
WIBW Topeka· 20 hours agoNearly 20 years after it’s debut, health officials say the HPV vaccine is showing promise in...
New RSV shots tied to rare nervous system disorder — should you worry?
LiveScience· 1 day agoThe available vaccines include one called Arexvy and another called Abrysvo. The recent research —...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 5 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
Moderna Announces Positive Phase 3 Efficacy Data for mRNA-1283, the Company’s Next Generation...
Morningstar· 1 day agoCAMBRIDGE, MA / ACCESSWIRE / June 13, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that its Phase 3 trial of mRNA-1283, an investigational next-generation COVID-19 vaccine< ...
Combined COVID-flu vaccine shows positive results in late-stage trial, Moderna says
WISH-TV Indianapolis· 4 days agoOn Monday, vaccine maker Moderna announced positive late-stage trial results for its Covid-flu...
Moderna says new-generation COVID vaccine more effective than Spikevax in adults 18 and over
Morningstar· 1 day agoThe trial involved about 11,400 patients age 12 and older, half of whom were given mRNA-1283, the new vaccine, and half of whom were given Spikevax. "Today's vaccine ...